CVE-2014-7860

Description

The web/web_file/fb_publish.php script in D-Link DNS-320L before 1.04b12 and DNS-327L before 1.03b04 Build0119 does not authenticate requests, which allows remote attackers to obtain arbitrary photos and publish them to an arbitrary Facebook profile via a target album_id and access_token.

Category

5.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.64%
Third-Party Advisory packetstormsecurity.com Third-Party Advisory seclists.org Third-Party Advisory securityfocus.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://packetstormsecurity.com/files/132075/D-Link-Bypass-Buffer-Overflow.html vdb entry third party advisory
http://www.securityfocus.com/bid/74884 vdb entry third party advisory
http://www.securityfocus.com/archive/1/535626/100/200/threaded mailing list
http://seclists.org/fulldisclosure/2015/May/125 mailing list vdb entry third party advisory
http://www.search-lab.hu/media/D-Link_Security_advisory_3_0_public.pdf technical description

Frequently Asked Questions

What is the severity of CVE-2014-7860?
CVE-2014-7860 has been scored as a medium severity vulnerability.
How to fix CVE-2014-7860?
To fix CVE-2014-7860, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-7860 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2014-7860 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.